|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| 21/05 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| 30/04 | Arab Drug Company 9-month net profit EGP 196.4 million | RE |
| Market Cap | 288.56Cr 5.67Cr 4.86Cr 4.55Cr 4.16Cr 7.81Cr 542.67Cr 7.91Cr 54Cr 21Cr 272.61Cr 21Cr 21Cr 901.67Cr | P/E 2024 |
5.46x | P/E 2025 | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 331.85Cr 6.52Cr 5.59Cr 5.23Cr 4.79Cr 8.98Cr 624.07Cr 9.1Cr 62Cr 24Cr 313.5Cr 24Cr 24Cr 1.04TCr | EV / Sales 2024 |
0.98x | EV / Sales 2025 | 1.47x |
| Free-Float |
18.09% | Yield 2024 |
10.4% | Yield 2025 | 4.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | +6.38% | +76.40% | +126.75% | 1,11900Cr | |
| +1.07% | +3.80% | +50.73% | +62.78% | 65TCr | |
| +1.20% | +6.21% | +25.81% | +78.74% | 47TCr | |
| +1.02% | +5.77% | +43.63% | +48.43% | 37TCr | |
| +0.85% | +4.07% | +24.97% | +40.58% | 30TCr | |
| +1.26% | +6.81% | +2.27% | +14.41% | 26TCr | |
| +1.88% | +5.81% | +49.57% | +70.53% | 24TCr | |
| +1.59% | +2.09% | -17.33% | -52.62% | 21TCr | |
| +1.87% | +5.61% | +27.32% | +91.38% | 18TCr | |
| Average | +1.29% | +4.97% | +31.49% | +53.44% | 42.22TCr | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.26% | +72.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 79Cr 1.54Cr 1.32Cr 1.24Cr 1.13Cr 2.13Cr 147.72Cr 2.15Cr 15Cr 5.7Cr 74Cr 5.8Cr 5.67Cr 245.45Cr | 111.82Cr 2.2Cr 1.88Cr 1.76Cr 1.61Cr 3.03Cr 210.28Cr 3.07Cr 21Cr 8.12Cr 105.63Cr 8.25Cr 8.07Cr 349.39Cr |
| Net income | 10Cr 20.21L 17.31L 16.2L 14.83L 27.83L 19Cr 28.19L 1.91Cr 74.63L 9.71Cr 75.89L 74.24L 32Cr | 23Cr 44.79L 38.36L 35.9L 32.86L 61.67L 43Cr 62.48L 4.24Cr 1.65Cr 22Cr 1.68Cr 1.65Cr 71Cr |
| Net Debt | 28Cr 55.89L 47.88L 44.8L 41.01L 76.96L 53Cr 77.98L 5.29Cr 2.06Cr 27Cr 2.1Cr 2.05Cr 89Cr | 43Cr 85.08L 72.88L 68.19L 62.42L 1.17Cr 81Cr 1.19Cr 8.06Cr 3.14Cr 41Cr 3.19Cr 3.13Cr 135.26Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
